Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
47
Number of overlapping holdings
37.0%
% of BMED's 140 holdings also in XBI
34.6%
% of XBI's 136 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 2.6% | 2.5% | 2.5% |
|
AMGEN INC | 2.5% | 2.2% | 2.2% |
|
BIOMARIN PHARMACEUTICAL INC | 1.9% | 2.1% | 1.9% |
|
NEUROCRINE BIOSCIENCES INC | 1.3% | 2.8% | 1.3% |
|
BLUEPRINT MEDICINES CORP. | 1.3% | 1.7% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to XBI
|
BOSTON SCIENTIFIC CORP | 3.7% |
|
AMERISOURCEBERGEN CORP | 3.4% |
|
INTUITIVE SURGICAL INC | 2.8% |
 |
ARGENX SE ADR | 2.4% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.4% |
|
WEST PHARMACEUTICAL SERVICES | 2.3% |
|
DANAHER CORP | 2.0% |
|
BIO-TECHNE CORPORATION | 1.9% |
|
QIAGEN NV | 1.8% |
|
MCKESSON CORP | 1.7% |
BMED Underweight Relative to XBI
|
GILEAD SCIENCES INC | -3.0% |
|
NATERA INC | -2.9% |
|
ADVENTRX PHARMACEUTICALS INC | -2.8% |
|
INCYTE CORP | -2.5% |
|
ABBVIE INC | -2.4% |
|
EXACT SCIENCES CORP | -2.2% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.2% |
|
VERTEX PHARMACEUTICALS INC | -2.0% |
|
UNITED THERAPEUTICS CORP | -1.7% |
|
VIKING THERAPEUTICS, INC. | -1.7% |